Literature DB >> 31980531

Allosteric activation of MALT1 by its ubiquitin-binding Ig3 domain.

Rebekka Schairer1, Gareth Hall2,3, Ming Zhang1, Richard Cowan2,3, Roberta Baravalle2,3, Frederick W Muskett2,3, Peter J Coombs4, Chido Mpamhanga4, Lisa R Hale4, Barbara Saxty4, Justyna Iwaszkiewicz5, Chantal Décaillet1, Mai Perroud1, Mark D Carr6,3, Margot Thome7.   

Abstract

The catalytic activity of the protease MALT1 is required for adaptive immune responses and regulatory T (Treg)-cell development, while dysregulated MALT1 activity can lead to lymphoma. MALT1 activation requires its monoubiquitination on lysine 644 (K644) within the Ig3 domain, localized adjacent to the protease domain. The molecular requirements for MALT1 monoubiquitination and the mechanism by which monoubiquitination activates MALT1 had remained elusive. Here, we show that the Ig3 domain interacts directly with ubiquitin and that an intact Ig3-ubiquitin interaction surface is required for the conjugation of ubiquitin to K644. Moreover, by generating constitutively active MALT1 mutants that overcome the need for monoubiquitination, we reveal an allosteric communication between the ubiquitination site K644, the Ig3-protease interaction surface, and the active site of the protease domain. Finally, we show that MALT1 mutants that alter the Ig3-ubiquitin interface impact the biological response of T cells. Thus, ubiquitin binding by the Ig3 domain promotes MALT1 activation by an allosteric mechanism that is essential for its biological function.

Entities:  

Keywords:  T cell; protease; signaling; structure; ubiquitin

Mesh:

Substances:

Year:  2020        PMID: 31980531      PMCID: PMC7022147          DOI: 10.1073/pnas.1912681117

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Identification of paracaspases and metacaspases: two ancient families of caspase-like proteins, one of which plays a key role in MALT lymphoma.

Authors:  A G Uren; K O'Rourke; L A Aravind; M T Pisabarro; S Seshagiri; E V Koonin; V M Dixit
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

2.  Structural determinants of MALT1 protease activity.

Authors:  Christian Wiesmann; Lukas Leder; Jutta Blank; Anna Bernardi; Samu Melkko; Arnaud Decock; Allan D'Arcy; Frederic Villard; Paulus Erbel; Nicola Hughes; Felix Freuler; Rainer Nikolay; Juliano Alves; Frederic Bornancin; Martin Renatus
Journal:  J Mol Biol       Date:  2012-02-23       Impact factor: 5.469

3.  T-cell receptor-induced JNK activation requires proteolytic inactivation of CYLD by MALT1.

Authors:  Jens Staal; Yasmine Driege; Tine Bekaert; Annelies Demeyer; David Muyllaert; Petra Van Damme; Kris Gevaert; Rudi Beyaert
Journal:  EMBO J       Date:  2011-03-29       Impact factor: 11.598

4.  The protease activity of the paracaspase MALT1 is controlled by monoubiquitination.

Authors:  Christiane Pelzer; Katrin Cabalzar; Annette Wolf; Montserrat Gonzalez; Georg Lenz; Margot Thome
Journal:  Nat Immunol       Date:  2013-02-17       Impact factor: 25.606

5.  The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.

Authors:  Lijun Sun; Li Deng; Chee-Kwee Ea; Zong-Ping Xia; Zhijian J Chen
Journal:  Mol Cell       Date:  2004-05-07       Impact factor: 17.970

6.  E3-independent monoubiquitination of ubiquitin-binding proteins.

Authors:  Daniela Hoeller; Christina-Maria Hecker; Sebastian Wagner; Vladimir Rogov; Volker Dötsch; Ivan Dikic
Journal:  Mol Cell       Date:  2007-06-22       Impact factor: 17.970

7.  Differential requirement for Malt1 in T and B cell antigen receptor signaling.

Authors:  Jürgen Ruland; Gordon S Duncan; Andrew Wakeham; Tak W Mak
Journal:  Immunity       Date:  2003-11       Impact factor: 31.745

8.  Pharmacological inhibition of MALT1 protease activity protects mice in a mouse model of multiple sclerosis.

Authors:  Conor Mc Guire; Lynn Elton; Peter Wieghofer; Jens Staal; Sofie Voet; Annelies Demeyer; Daniel Nagel; Daniel Krappmann; Marco Prinz; Rudi Beyaert; Geert van Loo
Journal:  J Neuroinflammation       Date:  2014-07-21       Impact factor: 8.322

9.  Bcl10-controlled Malt1 paracaspase activity is key for the immune suppressive function of regulatory T cells.

Authors:  Marc Rosenbaum; Andreas Gewies; Konstanze Pechloff; Christoph Heuser; Thomas Engleitner; Torben Gehring; Lara Hartjes; Sabrina Krebs; Daniel Krappmann; Mark Kriegsmann; Wilko Weichert; Roland Rad; Christian Kurts; Jürgen Ruland
Journal:  Nat Commun       Date:  2019-05-28       Impact factor: 14.919

10.  Monoubiquitination and activity of the paracaspase MALT1 requires glutamate 549 in the dimerization interface.

Authors:  Katrin Cabalzar; Christiane Pelzer; Annette Wolf; Georg Lenz; Justyna Iwaszkiewicz; Vincent Zoete; Stephan Hailfinger; Margot Thome
Journal:  PLoS One       Date:  2013-08-19       Impact factor: 3.240

View more
  3 in total

1.  Mechanistic impact of oligomer poisoning by dominant-negative CARD11 variants.

Authors:  Jacquelyn R Bedsaul; Neha Shah; Shelby M Hutcherson; Joel L Pomerantz
Journal:  iScience       Date:  2022-01-22

2.  A20 and ABIN-1 cooperate in balancing CBM complex-triggered NF-κB signaling in activated T cells.

Authors:  Hongli Yin; Ozge Karayel; Ying-Yin Chao; Thomas Seeholzer; Isabel Hamp; Oliver Plettenburg; Torben Gehring; Christina Zielinski; Matthias Mann; Daniel Krappmann
Journal:  Cell Mol Life Sci       Date:  2022-01-31       Impact factor: 9.261

3.  Assignment of IVL-Methyl side chain of the ligand-free monomeric human MALT1 paracaspase-IgL3 domain in solution.

Authors:  Xiao Han; Maria Levkovets; Dmitry Lesovoy; Renhua Sun; Johan Wallerstein; Tatyana Sandalova; Tatiana Agback; Adnane Achour; Peter Agback; Vladislav Yu Orekhov
Journal:  Biomol NMR Assign       Date:  2022-09-12       Impact factor: 0.731

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.